ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A short-term cost-utility analysis of insulin degludec versus insulin glargine U100 in patients with type 1 or type 2 diabetes in Denmark
Journal of Medical Economics
◽
10.1080/13696998.2016.1245663
◽
2016
◽
Vol 20
(3)
◽
pp. 213-220
◽
Cited By ~ 8
Author(s):
R. F. Pollock
◽
C. K. Tikkanen
Keyword(s):
Type 2 Diabetes
◽
Insulin Glargine
◽
Cost Utility
◽
Cost Utility Analysis
◽
Insulin Degludec
◽
Utility Analysis
◽
Short Term
Download Full-text
Related Documents
Cited By
References
PDB79 - COST-UTILITY ANALYSIS OF INSULIN GLARGINE 300 U/ML VERSUS INSULIN GLARGINE 100 U/ML AND INSULIN DEGLUDEC 100 U/ML IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CROATIA
Value in Health
◽
10.1016/j.jval.2018.09.784
◽
2018
◽
Vol 21
◽
pp. S131-S132
Author(s):
M. Bogdanovic
◽
M. Fournier
◽
D. Vitezic
Keyword(s):
Diabetes Mellitus
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Insulin Glargine
◽
Cost Utility
◽
Cost Utility Analysis
◽
Insulin Degludec
◽
Utility Analysis
Download Full-text
PDB86 - COST-UTILITY ANALYSIS OF INSULIN GLARGINE 300 U/ML VERSUS INSULIN GLARGINE 100 U/ML AND INSULIN DEGLUDEC 100 U/ML IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN BULGARIA
Value in Health
◽
10.1016/j.jval.2018.09.791
◽
2018
◽
Vol 21
◽
pp. S133
Author(s):
M. Bogdanovic
◽
J. Mihajlović
◽
M. Fournier
Keyword(s):
Diabetes Mellitus
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Insulin Glargine
◽
Cost Utility
◽
Cost Utility Analysis
◽
Insulin Degludec
◽
Utility Analysis
Download Full-text
Cost-Utility analysis of Insulin Degludec vs. Insulin Glargine U100 Treatment in Patients with Diabetes Mellitus type 1 and 2 in Serbia
Value in Health
◽
10.1016/j.jval.2016.09.1885
◽
2016
◽
Vol 19
(7)
◽
pp. A674-A675
Author(s):
M Culic
◽
M Russel-Szymczyk
◽
B Chubb
◽
C Tikkanen
Keyword(s):
Diabetes Mellitus
◽
Insulin Glargine
◽
Diabetes Mellitus Type 1
◽
Cost Utility
◽
Cost Utility Analysis
◽
Insulin Degludec
◽
Diabetes Mellitus Type
◽
Utility Analysis
◽
Patients With Diabetes
Download Full-text
Long-term cost-utility analysis of exenatide once weekly versus insulin glargine for the treatment of type 2 diabetes patients in the US
Journal of Medical Economics
◽
10.3111/13696998.2012.708691
◽
2012
◽
Vol 15
(sup2)
◽
pp. 6-13
◽
Cited By ~ 20
Author(s):
Yevgeniy Samyshkin
◽
Anne-Laure Guillermin
◽
Jennie H. Best
◽
Steven C. Brunell
◽
Adam Lloyd
Keyword(s):
Type 2 Diabetes
◽
Insulin Glargine
◽
Cost Utility
◽
Cost Utility Analysis
◽
Utility Analysis
◽
The Us
◽
Diabetes Patients
Download Full-text
DEVOTE 5: Evaluating the Short-Term Cost-Utility of Insulin Degludec Versus Insulin Glargine U100 in Basal–Bolus Regimens for Type 2 Diabetes in the UK
Diabetes Therapy
◽
10.1007/s13300-018-0430-4
◽
2018
◽
Vol 9
(3)
◽
pp. 1217-1232
◽
Cited By ~ 8
Author(s):
Richard F. Pollock
◽
◽
William J. Valentine
◽
Steven P. Marso
◽
Jens Gundgaard
◽
...
Keyword(s):
Type 2 Diabetes
◽
Insulin Glargine
◽
Cost Utility
◽
Insulin Degludec
◽
Short Term
◽
The Uk
◽
Basal Bolus
Download Full-text
A cost–utility analysis of dulaglutide versus insulin glargine as third-line therapy for Type 2 diabetes in Canada
Journal of Comparative Effectiveness Research
◽
10.2217/cer-2018-0073
◽
2019
◽
Vol 8
(4)
◽
pp. 229-240
◽
Cited By ~ 2
Author(s):
Richard F Pollock
◽
Kirsi Norrbacka
◽
Chris Cameron
◽
Leonardo Mancillas-Adame
◽
Mark Jeddi
Keyword(s):
Type 2 Diabetes
◽
Insulin Glargine
◽
Cost Utility
◽
Cost Utility Analysis
◽
Utility Analysis
◽
Line Therapy
◽
Third Line Therapy
◽
Third Line
Download Full-text
PDB45 EVALUATING THE SHORT-TERM COST-UTILITY OF INSULIN DEGLUDEC VERSUS INSULIN GLARGINE U100 IN BASAL-BOLUS REGIMENS FOR TYPE 2 DIABETES IN CHINA
Value in Health
◽
10.1016/j.jval.2019.04.595
◽
2019
◽
Vol 22
◽
pp. S147-S148
Author(s):
S. Han
◽
L.W. Shi
◽
H.K. SUN
◽
P.X. Dong
◽
L.Y. Zheng
Keyword(s):
Type 2 Diabetes
◽
Insulin Glargine
◽
Cost Utility
◽
Insulin Degludec
◽
Short Term
◽
Basal Bolus
Download Full-text
Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: a cost-utility analysis based on the EXSCEL trial
Diabetes Research and Clinical Practice
◽
10.1016/j.diabres.2021.109152
◽
2021
◽
pp. 109152
Author(s):
Frauke Becker
◽
Helen A. Dakin
◽
Shelby D. Reed
◽
Yanhong Li
◽
José Leal
◽
...
Keyword(s):
Type 2 Diabetes
◽
Cost Effectiveness
◽
Lifetime Cost
◽
Cost Utility
◽
Cost Utility Analysis
◽
Utility Analysis
Download Full-text
Cost-utility analysis in a UK setting of self-monitoring of blood glucose in patients with type 2 diabetes
Current Medical Research and Opinion
◽
10.1185/030079906x104669
◽
2006
◽
Vol 22
(5)
◽
pp. 861-872
◽
Cited By ~ 33
Author(s):
Andrew J. Palmer
◽
Sean Dinneen
◽
James R. Gavin III
◽
Alastair Gray
◽
William H. Herman
◽
...
Keyword(s):
Type 2 Diabetes
◽
Blood Glucose
◽
Cost Utility
◽
Cost Utility Analysis
◽
Utility Analysis
◽
Self Monitoring
Download Full-text
Cost-Utility Analysis of Intensive Blood Glucose Control with Metformin versus Usual Care in Overweight Type 2 Diabetes Mellitus Patients in Beijing, P.R. China
Value in Health
◽
10.1111/j.1524-4733.2008.00363.x
◽
2008
◽
Vol 11
◽
pp. S23-S32
◽
Cited By ~ 16
Author(s):
Xuanqian Xie
◽
Hindrik Vondeling
Keyword(s):
Diabetes Mellitus
◽
Type 2 Diabetes
◽
Type 2 Diabetes Mellitus
◽
Blood Glucose
◽
Glucose Control
◽
Blood Glucose Control
◽
Cost Utility
◽
Cost Utility Analysis
◽
Utility Analysis
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close